Results 91 to 100 of about 1,421 (178)

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study. [PDF]

Drugs Real World Outcomes, 2020
Szerman N, Basurte-Villamor I, Vega P, Martinez-Raga J, Parro-Torres C, Cambra Almerge J, Grau-López L, De Matteis M, Arias F.   +8 more
europepmc   +1 more source

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort. [PDF]

Open Forum Infect Dis
Rial-Crestelo D, Llenas-García J, Hidalgo-Tenorio C, Troya García J, Galindo Puerto MJ, Alemán Valls MR, Torralba González de Suso M, Buzón L, Díaz de Santiago A, Rodríguez A, Calzado Isbert S, Aguilera García M, Morano Amado LE, Vinuesa García D, Bernal Morell E, Martínez Álvarez RM, Cabello-Clotet N, Fernández A, Montero Hernández MDC, Díez Romero C, Calderón Hernaiz R, Pérez Martínez D, Gisbert Pérez L, Arenas García V, Escrich C, Fariñas Álvarez MC, Lucas Dato A, Losa García JE, Pernas Pardavila H, Gainzarain JC, Estébanez M, Barragán Gallo P, Clavero Olmos M, Egido Murciano MV, Benéitez OLF, Pedrero-Tomé R, Cabello-Úbeda A, Martín-Carbonero L, RELATIVITY studygroup.   +38 more
europepmc   +1 more source

GATA3 as a Blood-Based RNA Biomarker for Idiopathic Parkinson's Disease. [PDF]

Int J Mol Sci, 2023
Acharya S, Lumley AI, Zhang L, Vausort M, Devaux Y, On Behalf Of The Ncer-Pd Consortium.   +5 more
europepmc   +1 more source

Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson's disease. [PDF]

NPJ Digit Med
Loo RTJ, Pavelka L, Mangone G, Khoury F, Vidailhet M, Corvol JC, Glaab E, NCER-PD Consortium.   +7 more
europepmc   +1 more source

Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson's disease over seven years in a cohort: a comparative analysis. [PDF]

BMC Med Res Methodol
Hanff AM, Krüger R, McCrum C, Ley C, NCER-PD.   +4 more
europepmc   +1 more source

Interpretable Machine Learning for Cross-Cohort Prediction of Motor Fluctuations in Parkinson's Disease. [PDF]

Mov Disord
Loo RTJ, Pavelka L, Mangone G, Khoury F, Vidailhet M, Corvol JC, Krüger R, Glaab E, NCER‐PD Consortium.   +8 more
europepmc   +1 more source

Cardiovascular history and risk of idiopathic Parkinson's disease: a cross-sectional observational study. [PDF]

BMC Neurosci
Acharya S, Lumley AI, Devaux Y, NCER-PD Consortium.   +3 more
europepmc   +1 more source

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment. [PDF]

Neuropsychiatr Dis Treat, 2022
Basurte-Villamor I, Vega P, Vega P, Roncero C, Martínez-Raga J, Grau-López L, Aguilar L, Torrens M, Szerman N.   +8 more
europepmc   +1 more source

Genetic landscape of Parkinson's disease and related diseases in Luxembourg. [PDF]

Front Aging Neurosci, 2023
Landoulsi Z, Pachchek S, Bobbili DR, Pavelka L, May P, Krüger R, NCER-PD Consortium.   +6 more
europepmc   +1 more source

Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Aho VTE, Klee M, Landoulsi Z, Heintz-Buschart A, Pavelka L, Leist AK, Krüger R, May P, Wilmes P, NCER-PD Consortium.   +9 more
europepmc   +1 more source